AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATED WITH A SOD1 GENE MUTATION

Clinical trials for AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATED WITH A SOD1 GENE MUTATION explained in plain language.

Never miss a new study

Get alerted when new AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATED WITH A SOD1 GENE MUTATION trials appear

Sign up with your email to follow new studies for AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATED WITH A SOD1 GENE MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Race to stop ALS before it starts in High-Risk families

Prevention Ongoing

This study is testing whether a drug called tofersen can delay or prevent the onset of ALS in adults who carry a specific genetic mutation (SOD1) and show early biological signs of the disease but do not yet have any symptoms. The trial will compare the drug to a placebo in about…

Matched conditions: AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATED WITH A SOD1 GENE MUTATION

Phase: PHASE3 • Sponsor: Biogen • Aim: Prevention

Last updated Apr 03, 2026 14:41 UTC

AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATED WITH A SOD1 GENE MUTATION

Get alerted when new AMYOTROPHIC LATERAL SCLEROSIS ASSOCIATED WITH A SOD1 GENE MUTATION trials appear

Race to stop ALS before it starts in High-Risk families